ArticleDose-response : a publication of International Hormesis Society

Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II-III Esophageal Squamous Cell Carcinoma.

Huiping Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.